Joint

Joint EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Joint (JYNT) as of Oct 6, 2026 is 738,722.00 USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -517,625.00 USD — a change of -242.71% (higher).

EBITDA

738,722.00USD

YoY

-242.71%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Joint is 2026 738,722.00 USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Joint was 2025 -517,625.00 USD. It decreases by -242.71% higher compared to the previous year.

The Joint EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
1.81 M USD
Jan 1, 2019
5.31 M USD
Jan 1, 2020
8.19 M USD
Jan 1, 2021
10.03 M USD
Jan 1, 2022
7.43 M USD
Jan 1, 2023
1.60 M USD
Jan 1, 2024
-517,625.00 USD
Jan 1, 2025
738,722.00 USD
The Joint EBITDA history
YEAREBITDAYoY
738,722.00USD-242.71%
-517,625.00USD-132.42%
1.60 MUSD-78.51%
7.43 MUSD-25.91%
10.03 MUSD+22.39%
8.19 MUSD+54.14%
5.31 MUSD+194.42%
1.81 MUSD-253.64%
-1.17 MUSD-90.54%
-12.42 MUSD+54.97%
-8.02 MUSD+461.88%
-1.43 MUSD—
Access this data via the Eulerpool API

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Joint is 738,722.00 USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Joint changed from -517,625.00 USD to 738,722.00 USD, representing a -242.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Joint since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Joint historically and in real time.

Access this data via the Eulerpool API

Income Statement — Joint

All Key Metrics — Joint